ARWR vs EIX · rev $829.4M vs P/E 7.3, rev $17.60B
Arrowhead Pharmaceuticals Inc (ARWR) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
ARWR currently screens at market cap $10.59B. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the ARWR and EIX stock pages for the full models.
Not investment advice.